N-acetylcysteine ameliorates amphotericin-induced nephropathy in rats

Nephron - Physiology

Volumn 99, Issue 1, 2005, Pages

  Feldman, Leonid ^a   Efrati, Shai ^a   Dishy, Victor ^a   Katchko, Leonid ^b   Berman, Sylvia ^a   Averbukh, Michael ^a   Aladjem, Mordechai ^a   Averbukh, Zhan ^a   Weissgarten, Joshua ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute renal failure; Amphotericin B; N acetylcysteine; Nephrotoxicity

Indexed keywords

ACETYLCYSTEINE; AMPHOTERICIN; MAGNESIUM; PENTETATE TECHNETIUM TC 99M; POTASSIUM; SODIUM;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HISTOLOGY; INJECTION SITE; ISOTOPE LABELING; KIDNEY NECROSIS; KIDNEY PRESERVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; URINALYSIS;

AMPHOTERICIN B; ANIMALS; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; KIDNEY DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 12444326166     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081799     Document Type: Article

References (32)

1. Bennett JE: Antifungal agents; in Hardman JG, Gilman AG, Limbrid LE (eds): Goodman & Gilman's The Pharmacological Basis of Therapeutics, ed 9. New York, McGraw-Hill, 1996, pp 1175-1190.
2. Gallis HA: Amphotericin B: A commentary on its role as an antifungal agent and as a comparative agent in clinical trials. Clin Infect Dis 1996;22:S145-S147.
3. Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Platt R: Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int 2001;60:1452-1459.
4. Sawaya BP, Briggs JP, Schnermann J: Amphotericin B nephrotoxicity: The adverse consequences of altered membrane properties. J Am Soc Nephrol 1995;6:154-164.
5. Barton CH, Pahl M, Vaziri ND, Cesario T: Renal magnesium wasting associated with amphotericin B therapy. Am J Med 1984;77:471-474.
6. Zager RA, Bredl CR, Schimpf BA: Direct amphotericin B-mediated tubular toxicity: Assessments of selected cytoprotective agents. Kidney Int 1992;41:1588-1594.
7. Heyman SN, Stillman IE, Brezis M, Epstein FH, Spokes K, Rosen S: Chronic amphotericin nephropathy: Morphometric, electron microscopic, and functional studies. J Am Soc Nephrol 1993;4:69-80.
8. Dorea EL, Yu L, De Castro I, Campos SB, Ori M, Vaccari EM, Lacaz CS, Seguro AC: Nephrotoxicity of amphotericin B is attenuated by solubilizing with lipid emulsion. J Am Soc Nephrol 1997;8:1415-1422.
9. Llanos A, Cieza J, Bernardo J, Echevarria J, Biaggioni I, Sabra R, Branch RA: Effect of salt supplementation on amphotericin B nephrotoxicity. Kidney Int 1991;40:302-308.
10. Tolins JP, Raij L: Chronic amphotericin B nephrotoxicity in the rat: Protective effect of calcium channel blockade. J Am Soc Nephrol 1991;2:98-102.
11. Canada T, Weavind L, Augustin K: Possible liposomal amphotericin B-induced nephrogenic diabetes insipidus. Ann Pharmacother 2003;37:70-73.
12. Aruoma OI, Halliwell B, Hoey BM, Butler J: The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-597.
13. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R: Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1853-1857.
14. Sehirli A, Sener G, Satiroglu H, Ayanoglu-Dulger G: Protective effect of N-acetylcysteine on renal ischemia/reperfusion injury in the rat. J Nephrol 2003;16:75-80.
15. Heyman S, Goldfarb M, Shina A, Karmeli F, Rosen S: N-acetylcysteine ameliorates renal microcirculation: Studies in rats. Kidney Int 2003;63:634-641.
16. Efrati S, Dishy V, Averbukh M, Blatt A, Krakover R, Weisgarten J, Morrow J, Stein M, Golik A: The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney Int 2003;64:2182-2187.
17. Sheikh-Hamad D, Timmins K, Jalali Z: Cisplatin-induced renal toxicity: Possible reversal by N-acetylcysteine treatment. J Am Soc Nephrol 1997;8:1640-1644.
18. Tariq M, Morais C, Sobki S, Sulaiman M, Khader A: N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 1999;14:923-929.
19. Mazzon E, Britti D, De Sarro A, Caputi A, Cuzzocrea S: Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Pharmacol 2001;424:75-83.
20. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-184.
21. Wispriyono B, Matsuoka M, Igisu H, Matsuno K: Protection from cadmium cytotoxicity by N-acetylcysteine in LLL-PK1 cells. J Pharmacol Exp Ther 1998;287:344-351.
22. Girardi G, Elias MM: Effectiveness of N-acetylcysteine in protecting against mercuric chloride-induced nephrotoxicity. Toxicology 1991;67:155-164.
23. LeBrun M, Grenier L, Bergeron M, Thibault L, Labrecque G, Beauchamp D: Effect of fasting on temporal variation in the nephrotoxicity of amphotericin B in rats. Antimicrob Agents Chemother 1999;43:520-524.
24. Bryan C, Jarchow R, Maher J: Measurement of glomerular filtration rate in small animals without urine collection. J Lab Clin Med 1972;80:845-856.
25. Conesa EL, Valero F, Nadal JC, Fenoy FJ, Lopes B, Arregui B, Salom MG: N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol 2001;218:R730-R737.
26. Fenoy FG, Ferrer P, Carbonell L, Garcia-Salom M: Role of nitric oxide on papillary blood flow and pressure natriuresis. Hypertension 1995;25:408-414.
27. Dobashi K, Singh I, Orak JK, Asayama K, Singh AK: Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney. Mol Cell Biochem 2002;240:9-17.
28. Horowitz JD: Thiol-containing agents in the management of unstable angina pectoris and acute myocardial infarction. Am J Med 1991;30:113S-117S.
29. Andrews NP, Prasad A, Quyyumi AA: N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 2001;37:117-123.
30. Beckman JK, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
31. Beretta S, Sala G, Mattavelli L, Ceresa C, Casciati A, Ferri A, Carri MT, Ferrarese C: Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by Nacetylcysteine. Neurobiol Dis 2003;13:213-221.
32. Cuzzocrea S, Mazzon E, Costantino G, Serraino I, De Sarro A, Caputi AP: Effects of N-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc Res 2000;47:537-548.